2021 Q1 Form 10-Q Financial Statement

#000143774921012379 Filed on May 17, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $571.0K $439.0K
YoY Change 30.07% 20.6%
Cost Of Revenue $339.0K $260.0K
YoY Change 30.38% 35.42%
Gross Profit $232.0K $179.0K
YoY Change 29.61% 4.07%
Gross Profit Margin 40.63% 40.77%
Selling, General & Admin $1.763M $1.546M
YoY Change 14.04% 9.8%
% of Gross Profit 759.91% 863.69%
Research & Development $327.0K $335.0K
YoY Change -2.39% -21.36%
% of Gross Profit 140.95% 187.15%
Depreciation & Amortization $7.000K $16.00K
YoY Change -56.25% 0.0%
% of Gross Profit 3.02% 8.94%
Operating Expenses $2.090M $1.881M
YoY Change 11.11% 2.56%
Operating Profit -$1.858M -$1.702M
YoY Change 9.17% 2.41%
Interest Expense $93.00K $757.0K
YoY Change -87.71% -23.15%
% of Operating Profit
Other Income/Expense, Net -$20.00K -$914.0K
YoY Change -97.81% -15.92%
Pretax Income -$1.878M -$2.616M
YoY Change -28.21% -4.84%
Income Tax
% Of Pretax Income
Net Earnings -$1.878M -$2.616M
YoY Change -28.21% -4.84%
Net Earnings / Revenue -328.9% -595.9%
Basic Earnings Per Share -$0.01
Diluted Earnings Per Share -$6.978K -$13.47K
COMMON SHARES
Basic Shares Outstanding 233.7M 168.9M
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.341M $744.0K
YoY Change 80.24% 45.31%
Cash & Equivalents $1.341M $744.0K
Short-Term Investments
Other Short-Term Assets $62.00K $44.00K
YoY Change 40.91% 29.41%
Inventory $242.0K $33.00K
Prepaid Expenses
Receivables $277.0K $259.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.922M $1.080M
YoY Change 77.96% 38.11%
LONG-TERM ASSETS
Property, Plant & Equipment $63.00K $63.00K
YoY Change 0.0% -87.62%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $53.00K $99.00K
YoY Change -46.46%
Other Assets $35.00K $35.00K
YoY Change 0.0% -83.41%
Total Long-Term Assets $3.415M $2.476M
YoY Change 37.92% -5.24%
TOTAL ASSETS
Total Short-Term Assets $1.922M $1.080M
Total Long-Term Assets $3.415M $2.476M
Total Assets $5.337M $3.556M
YoY Change 50.08% 4.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $685.0K $430.0K
YoY Change 59.3% 16.22%
Accrued Expenses $508.0K $496.0K
YoY Change 2.42% 31.56%
Deferred Revenue $45.00K $9.000K
YoY Change 400.0%
Short-Term Debt $1.207M $1.107M
YoY Change 9.03% 20.33%
Long-Term Debt Due $448.0K $2.689M
YoY Change -83.34% 88.57%
Total Short-Term Liabilities $2.973M $4.731M
YoY Change -37.16% 51.39%
LONG-TERM LIABILITIES
Long-Term Debt $481.0K $700.0K
YoY Change -31.29% -43.64%
Other Long-Term Liabilities $1.111M $914.0K
YoY Change 21.55% 11.33%
Total Long-Term Liabilities $1.592M $700.0K
YoY Change 127.43% -66.07%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.973M $4.731M
Total Long-Term Liabilities $1.592M $700.0K
Total Liabilities $4.565M $6.192M
YoY Change -26.28% 13.05%
SHAREHOLDERS EQUITY
Retained Earnings -$133.7M -$125.9M
YoY Change 6.2%
Common Stock $161.0K $119.0K
YoY Change 35.29%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.749M -$2.725M
YoY Change
Total Liabilities & Shareholders Equity $5.337M $3.556M
YoY Change 50.08% 4.74%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income -$1.878M -$2.616M
YoY Change -28.21% -4.84%
Depreciation, Depletion And Amortization $7.000K $16.00K
YoY Change -56.25% 0.0%
Cash From Operating Activities -$845.0K -$753.0K
YoY Change 12.22% -13.35%
INVESTING ACTIVITIES
Capital Expenditures -$10.00K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 -$84.00K
YoY Change -100.0%
Cash From Investing Activities -$10.00K -$84.00K
YoY Change -88.1%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $2.106M $901.0K
YoY Change 133.74%
Debt Paid & Issued, Net $650.0K
YoY Change
Cash From Financing Activities $1.482M 926.0K
YoY Change 60.04% 26.85%
NET CHANGE
Cash From Operating Activities -$845.0K -753.0K
Cash From Investing Activities -$10.00K -84.00K
Cash From Financing Activities $1.482M 926.0K
Net Change In Cash $625.0K 89.00K
YoY Change 602.25% -164.03%
FREE CASH FLOW
Cash From Operating Activities -$845.0K -$753.0K
Capital Expenditures -$10.00K
Free Cash Flow -$835.0K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 blgo Adjustments To Additional Paid In Capital Warrants And Conversion Feature Issued
AdjustmentsToAdditionalPaidInCapitalWarrantsAndConversionFeatureIssued
35000
CY2021Q1 blgo Allocation Of Stock Option Expense Within Noncontrolling Interest
AllocationOfStockOptionExpenseWithinNoncontrollingInterest
313000
CY2020Q1 blgo Allocation Of Stock Option Expense Within Noncontrolling Interest
AllocationOfStockOptionExpenseWithinNoncontrollingInterest
448000
CY2021Q1 blgo Class Of Warrant Or Right Aggregate Value Of Warrants Or Rights
ClassOfWarrantOrRightAggregateValueOfWarrantsOrRights
609000
CY2021Q1 blgo Class Of Warrant Or Right Expired During Period
ClassOfWarrantOrRightExpiredDuringPeriod
746528
CY2020Q1 blgo Class Of Warrant Or Right Expired During Period
ClassOfWarrantOrRightExpiredDuringPeriod
266000
CY2021Q1 blgo Class Of Warrant Or Right Issued During Period
ClassOfWarrantOrRightIssuedDuringPeriod
1975000
CY2020Q1 blgo Class Of Warrant Or Right Issued During Period
ClassOfWarrantOrRightIssuedDuringPeriod
791260
CY2021Q1 blgo Commitment Fee Recorded As Additional Paid In Capital
CommitmentFeeRecordedAsAdditionalPaidInCapital
CY2020Q1 blgo Commitment Fee Recorded As Additional Paid In Capital
CommitmentFeeRecordedAsAdditionalPaidInCapital
-122000
CY2021Q1 blgo Deemed Dividend For The Change In Accounting For Derivative Liability
DeemedDividendForTheChangeInAccountingForDerivativeLiability
-247000
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
138363000
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
135849000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
424000
CY2020Q1 blgo Deemed Dividend For The Change In Accounting For Derivative Liability
DeemedDividendForTheChangeInAccountingForDerivativeLiability
-342000
CY2021Q1 blgo Deemed Dividends
DeemedDividends
CY2020Q1 blgo Deemed Dividends
DeemedDividends
100000
CY2020Q1 blgo Equity Increase Decrease Dividends Deemed Due To A New Accounting Principle Adoption
EquityIncreaseDecreaseDividendsDeemedDueToANewAccountingPrincipleAdoption
CY2021Q1 blgo Finitelived Tangible Assets Net
FinitelivedTangibleAssetsNet
2808000
CY2020Q4 blgo Finitelived Tangible Assets Net
FinitelivedTangibleAssetsNet
2388000
CY2021Q1 blgo Gain From Ppp Loan Forgiveness
GainFromPPPLoanForgiveness
43000
CY2020Q1 blgo Gain From Ppp Loan Forgiveness
GainFromPPPLoanForgiveness
CY2021Q1 blgo Increase Decrease In Liability For Customer Deposits
IncreaseDecreaseInLiabilityForCustomerDeposits
80000
CY2020Q1 blgo Increase Decrease In Liability For Customer Deposits
IncreaseDecreaseInLiabilityForCustomerDeposits
-1000
CY2021Q1 blgo Liability For Customer Deposits Current
LiabilityForCustomerDepositsCurrent
80000
CY2020Q4 blgo Liability For Customer Deposits Current
LiabilityForCustomerDepositsCurrent
CY2021Q1 blgo Noncontrolling Interest Decrease From Allocation
NoncontrollingInterestDecreaseFromAllocation
CY2021Q1 blgo Nonoperating Income Grant Income
NonoperatingIncomeGrantIncome
30000
CY2020Q1 blgo Nonoperating Income Grant Income
NonoperatingIncomeGrantIncome
57000
CY2021Q1 blgo Note Payable And Line Of Credit Current
NotePayableAndLineOfCreditCurrent
CY2020Q4 blgo Note Payable And Line Of Credit Current
NotePayableAndLineOfCreditCurrent
100000
CY2021Q1 blgo Number Of Wholly Owned Subsidiaries
NumberOfWhollyOwnedSubsidiaries
4
CY2020Q1 blgo Price Range Warrants Expired
PriceRangeWarrantsExpired
0.30
CY2020Q1 blgo Price Range Warrants Issued
PriceRangeWarrantsIssued
0.13
CY2020Q1 blgo Price Range Warrants Outstanding
PriceRangeWarrantsOutstanding
CY2021Q1 blgo Profit Loss Including Deemed Dividends For The Change Accounting For Derivative Liability
ProfitLossIncludingDeemedDividendsForTheChangeAccountingForDerivativeLiability
-1878000
CY2020Q1 blgo Profit Loss Including Deemed Dividends For The Change Accounting For Derivative Liability
ProfitLossIncludingDeemedDividendsForTheChangeAccountingForDerivativeLiability
-2616000
CY2020Q1 blgo Stock Issued During Period Value Financing Fees
StockIssuedDuringPeriodValueFinancingFees
-122000
CY2021Q1 blgo Stock Issued During Period Value Issued For Unpaid Salary And Business Expenses
StockIssuedDuringPeriodValueIssuedForUnpaidSalaryAndBusinessExpenses
31000
CY2020Q1 blgo Stock Issued During Period Value Paid For Interest
StockIssuedDuringPeriodValuePaidForInterest
4000
CY2020Q1 blgo Stockholders Equity Allocation Of Noncontrolling Interest From Subsidiarys Equity Issuance
StockholdersEquityAllocationOfNoncontrollingInterestFromSubsidiarysEquityIssuance
CY2021Q1 blgo Working Capital Deficit
WorkingCapitalDeficit
-1051000
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000880242
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
243391521
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
BIOLARGO, INC.
CY2021Q1 dei Entity Shell Company
EntityShellCompany
false
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2021Q1 dei Security12b Title
Security12bTitle
Common stock
CY2021Q1 dei Trading Symbol
TradingSymbol
blgo
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
277000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
484000
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-103000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-101000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
320000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
13000
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
13000
CY2021Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
46000
CY2020Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
668000
CY2021Q1 us-gaap Assets
Assets
5337000
CY2020Q4 us-gaap Assets
Assets
4942000
CY2021Q1 us-gaap Assets Current
AssetsCurrent
1922000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
1505000
CY2021Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
3415000
CY2020Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
3437000
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1341000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
716000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
716000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
655000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1341000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
744000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
625000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
89000
CY2020Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
32980989
CY2021Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
34209461
CY2019Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
43231161
CY2020Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
43756421
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00067
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00067
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
239963788
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
225885682
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
161000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
151000
CY2020Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
1106000
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
339000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1633000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2274000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-247000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-342000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-1880000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-2616000
CY2021Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 36pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;">Credit Concentration</div></div></div></div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">We have a limited number of customers that account for significant portions of our revenue. During the <div style="display: inline; font-style: italic; font: inherit;">three</div> months ended <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2021 </div>and <div style="display: inline; font-style: italic; font: inherit;">2020,</div> we had the following customers that accounted for more than <div style="display: inline; font-style: italic; font: inherit;">10%</div> of consolidated revenues, as follows:</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; margin-left: 10%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: thin solid rgb(0, 0, 0); border-top: thin solid rgb(0, 0, 0);">&nbsp;</td> <td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; border-bottom: thin solid rgb(0, 0, 0); border-top: thin solid rgb(0, 0, 0);">&nbsp;</td> <td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 2pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: thin solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt 0pt 0pt 2pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">March 31, </div><br /> <div style="display: inline; font-weight: bold;">2021</div></div></div> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: thin solid rgb(0, 0, 0);">&nbsp;</td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: thin solid rgb(0, 0, 0);">&nbsp;</td> <td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: thin solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">March 31, </div></div></div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2020</div></div></div> </td> <td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman; font-size: 10pt; width: 62%;"> <div style=" font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Customer A</div> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">39</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">&lt;10</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman; font-size: 10pt;"> <div style=" font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Customer B</div> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">16</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">11</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman; font-size: 10pt;"> <div style=" font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Customer C</div> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">13</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">&lt;10</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman; font-size: 10pt;"> <div style=" font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Customer D</div> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">12</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">14</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: thin solid rgb(0, 0, 0);"> <div style=" font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Customer E</div> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; border-bottom: thin solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">&lt;10</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">%</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">10</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">%</td> </tr> </table> </div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">We had <div style="display: inline; font-style: italic; font: inherit;">three</div> customers that each accounted for more than <div style="display: inline; font-style: italic; font: inherit;">10%</div> of consolidated accounts receivable at <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2021, </div>and <div style="display: inline; font-style: italic; font: inherit;">two</div> customers at <div style="display: inline; font-style: italic; font: inherit;"> December&nbsp;</div><div style="display: inline; font-style: italic; font: inherit;">31,</div> <div style="display: inline; font-style: italic; font: inherit;">2020,</div> as follows:</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; margin-left: 10%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman; font-size: 10pt; border-top: thin solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="font-family: Times New Roman; font-size: 10pt; border-top: thin solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-top: thin solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">March 31, 2021</div></div></div></div> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-top: thin solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="font-family: Times New Roman; font-size: 10pt; border-top: thin solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-top: thin solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;text-indent:-5pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">December 31, 2020</div></div></div></div> </td> <td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman; font-size: 10pt; width: 62%;"> <div style=" font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Customer D</div> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">29</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">&lt;10</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman; font-size: 10pt;"> <div style=" font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Customer E</div> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">13</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">&lt;10</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman; font-size: 10pt;"> <div style=" font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Customer F</div> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">12</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">&lt;10</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman; font-size: 10pt;"> <div style=" font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Customer G</div> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">&lt;10</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">32</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Customer H</div> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">&lt;10</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">%</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">10</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">%</td> </tr> </table> </div></div></div></div></div></div></div></div></div></div>
CY2021Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
45000
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
48000
CY2021Q1 us-gaap Convertible Debt
ConvertibleDebt
406000
CY2021Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
506000
CY2020Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
260000
CY2021Q1 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
CY2020Q1 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
434000
CY2021Q1 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
CY2020Q1 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
434000
CY2021Q1 us-gaap Debt Current
DebtCurrent
448000
CY2020Q4 us-gaap Debt Current
DebtCurrent
1102000
CY2021Q1 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
58000
CY2020Q4 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
104000
CY2021Q1 us-gaap Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
33000
CY2020Q4 us-gaap Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
CY2021Q1 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
929000
CY2020Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1609000
CY2021Q1 us-gaap Depreciation
Depreciation
7000
CY2020Q1 us-gaap Depreciation
Depreciation
16000
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2021Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-2000
CY2020Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
CY2021Q1 us-gaap Equity Method Investments
EquityMethodInvestments
53000
CY2020Q4 us-gaap Equity Method Investments
EquityMethodInvestments
63000
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2150000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2150000
CY2021Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
CY2020Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-214000
CY2021Q1 us-gaap Gross Profit
GrossProfit
232000
CY2020Q1 us-gaap Gross Profit
GrossProfit
179000
CY2021Q1 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2020Q1 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-10000
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
CY2021Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2020Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
2000
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-206000
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-96000
CY2021Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-4000
CY2020Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-26000
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-36000
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
17000
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
34000
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5000
CY2021Q1 us-gaap Interest Expense
InterestExpense
93000
CY2020Q1 us-gaap Interest Expense
InterestExpense
757000
CY2021Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
93000
CY2020Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
757000
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
26000
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
25000
CY2021Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
151000
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
166000
CY2021Q1 us-gaap Inventory Net
InventoryNet
242000
CY2020Q4 us-gaap Inventory Net
InventoryNet
277000
CY2021Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
91000
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
111000
CY2020Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
3000
CY2021Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
3000
CY2021Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
111000
CY2020Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
178000
CY2021Q1 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.18
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
479000
CY2021Q1 us-gaap Liabilities
Liabilities
4565000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-845000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-753000
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1631000
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2274000
CY2020Q1 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
25000
CY2021Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
4
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
2090000
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
1881000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1858000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1482000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
926000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-84000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1702000
CY2021Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
56000
CY2020Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
55000
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
114000
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00067
CY2020Q4 us-gaap Liabilities
Liabilities
5177000
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5337000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4942000
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2973000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3544000
CY2021Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1592000
CY2020Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1633000
CY2021Q1 us-gaap Line Of Credit
LineOfCredit
CY2020Q4 us-gaap Line Of Credit
LineOfCredit
50000
CY2021Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
481000
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
507000
CY2021Q1 us-gaap Minority Interest
MinorityInterest
-3977000
CY2020Q4 us-gaap Minority Interest
MinorityInterest
-4093000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
114000
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
211000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
226000
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
326000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
341000
CY2021Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
35000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
35000
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2000
CY2020Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-20000
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-914000
CY2021Q1 us-gaap Other Significant Noncash Transaction Value Of Consideration Given1
OtherSignificantNoncashTransactionValueOfConsiderationGiven1
35000
CY2020Q1 us-gaap Other Significant Noncash Transaction Value Of Consideration Given1
OtherSignificantNoncashTransactionValueOfConsiderationGiven1
CY2021Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
CY2020Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
4000
CY2021Q1 us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
10000
CY2020Q1 us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
-16000
CY2021Q1 us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
CY2020Q1 us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
100000
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00067
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
62000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
28000
CY2021Q1 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
788000
CY2020Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
788000
CY2021Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2106000
CY2020Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
901000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-1878000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-2616000
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
63000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
60000
CY2021Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1000
CY2020Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
CY2021Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
650000
CY2020Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
327000
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
335000
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-133672000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-132041000
CY2021Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
571000
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
439000
CY2021Q1 us-gaap Security Deposit
SecurityDeposit
35000
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1763000
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1546000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
585000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
526000
CY2020Q1 us-gaap Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Term1
ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm1
P2Y
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
4749000
CY2021Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q1 us-gaap Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Volatility Rate
ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate
1
CY2020Q1 us-gaap Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Volatility Rate
ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate
1.12
CY2021Q1 us-gaap Share Based Goods And Nonemployee Services Transaction Valuation Method Risk Free Interest Rate
ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate
0.0071
CY2020Q1 us-gaap Share Based Goods And Nonemployee Services Transaction Valuation Method Risk Free Interest Rate
ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate
0.0023
CY2021Q1 us-gaap Share Price
SharePrice
0.23
CY2021Q1 us-gaap Share Price
SharePrice
0.23
CY2021Q1 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Amount Noncurrent
SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent
900000
CY2020Q4 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Amount Noncurrent
SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent
900000
CY2020Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
434000
CY2021Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
111000
CY2020Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
178000
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2106000
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
901000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
3858000
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
772000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-235000
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2180000
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2636000
CY2021Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;">Use of Estimates </div></div></div></div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and revenues and expenses during the period reported. Actual results could differ from those estimates. Estimates are used when accounting for stock-based transactions, debt transactions, derivative liabilities, allowance for bad debt, asset depreciation and amortization, among others.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The methods, estimates and judgments we use in applying these most critical accounting policies have a significant impact on the results of our financial statements.</div></div></div></div></div></div></div></div></div></div>
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
233733015
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
168873233

Files In Submission

Name View Source Status
0001437749-21-012379-index-headers.html Edgar Link pending
0001437749-21-012379-index.html Edgar Link pending
0001437749-21-012379.txt Edgar Link pending
0001437749-21-012379-xbrl.zip Edgar Link pending
blgo-20210331.xml Edgar Link completed
blgo-20210331.xsd Edgar Link pending
blgo-20210331_cal.xml Edgar Link unprocessable
blgo-20210331_def.xml Edgar Link unprocessable
blgo-20210331_lab.xml Edgar Link unprocessable
blgo-20210331_pre.xml Edgar Link unprocessable
blgo20210331_10q.htm Edgar Link pending
ex_247264.htm Edgar Link pending
ex_247265.htm Edgar Link pending
ex_247266.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending